Abstract
PAX6, a paired box transcriptional factor, is considered as the master control gene for morphogenesis of the eye. Human PAX6 mutations have been associated with a range of eye abnormalities, including aniridia, various anterior segment defects and foveal hypoplasia. We carried out a mutational analysis of the PAX6 gene in 54 unrelated patients with aniridia or related syndromes. A deleterious variation was evidenced in 17 sporadic cases (50%) and in 13 (72%) familial cases. Twenty-four different mutations, 17 of which are novel, were found. The spectrum of PAX6 mutations was highly homogeneous: 23 mutations (96%) leading to premature stop codons (eight nonsense and four splice site mutations, 11 insertions and deletions) and only one (4%) missense mutation. Twenty-two mutations were associated with aniridia phenotypes whereas two were associated with atypical phenotypes. These latter encompassed a missense mutation (R19P) in an individual with a microphthalmia-sclerocornea and a splice site mutation (IVS4+5G>C) in a family presenting with a congenital nystagmus. Both represented the most probably hypomorphic alleles. Aniridia cases were associated with nonsense or frameshifting mutations. A careful examination of the phenotypes did not make it possible to recognise significant differences whenever the predicted protein was deprived of one or another of its functional domains. This strongly suggested that most of the truncating mutations generated null alleles by nonsense mediated mRNA decay. Our observations support the concept of dosage effects of the PAX6 mutations as well as presenting evidence for variable expressivity.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Nelson, LB, Spaeth, GL, Nowinski, TS, Margo, CE & Jackson, LA : A review. Surv Ophthalmol, (1984). 28, 621–642.
Hanson, IM, Fletcher, JM & Jordan, T et al : Mutations at the Pax6 locus are found in heterogeneous anterior segment malformations including Peters' anomaly. Nature Genet, (1994). 6, 168–173.
Prosser, J & van Heyningen, V : Pax6 mutations reviewed. Hum Mutation, (1998). 11, 93–108.
Chao, LY, Huff, V, Strong, LC & Saunders, GF : Mutation in the PAX6 gene in twenty patients with aniridia. Hum Mutation, (2000). 15, 332–339.
Gessler, M, Simola, KO & Bruns, GA : Cloning of breakpoints of a chromosome translocation identifies the AN2 locus. Science, (1989). 244, 1575–1578.
Davis, LM, Everest, AM, Simola, KO & Shows, TB : Long-range restriction map around 11p13 aniridia locus. Somat Cell Mol Genet, (1989). 15, 605–615.
Rose, EA, Glaser, T & Jones, C et al : Complete physical map of the WAGR region of 11p13 localizes a candidate Wilms' tumor gene. Cell, (1990). 60, 495–508.
Lyons, LA, Martha, A, Mintz-Hittner, HA, Saunders, GF & Ferrell, RE : Resolution of the two loci for autosomal dominant aniridia, AN1 and AN2, to a single locus on chromosome 11p13. Genomics, (1992). 13, 925–930.
Compton, DA, Weil, MM, Jones, C, Riccardi, VM, Strong, LC & Saunders, GF : Long range physical map of the Wilms' tumor-aniridia region on human chromosome 11. Cell, (1988). 55, 827–836.
Ton, CCT, Hirvonen, H & Miwa, H et al : Positional cloning and characterization of a paired box- and homeobox-containing gene from the aniridia region. Cell, (1991). 67, 1059–1074.
Glaser, T, Walton, DS & Maas, RL : Genomic structure, evolutionary conservation and aniridia mutations in the human PAX6 gene. Nature Genet, (1992). 2, 232–239.
Jordan, T, Hanson, I & Zaletayev, D et al : The human PAX6 gene is mutated in two patients with aniridia. Nature Genet, (1992). 1, 328–332.
Azuma, N, Nishina, S, Yanagisawa, H, Okuyama, T & Yamada, M : PAX6 missenses mutation in isolated foveal hypoplasia. Nature Genet, (1996). 13, 141–142.
Mirzayans, F, Pearce, WG, MacDonald, IM & Walter, MA : Mutations of the Pax6 gene in patients with autosomal dominant keratitis. Am J Hum Genet, (1995). 57, 539–548.
Hodgson, SV & Saunders, KE : A probable case of the homozygous condition of the aniridia gene. J Med Genet, (1980). 6, 478–480.
Glaser, T, Jepeal, L, Edwards, JG, Young, SR, Favor, J & Maas, RL : Pax6 gene dosage effect in a family with congenital cataracts, aniridia, anophtalmia and central nervous system defects. Nature Genet, (1994). 7, 463–471.
Love, J, Axton, R, Churchill, A, van Heyningen, V & Hanson, I : A new set of primers for mutation analysis of the human Pax6 gene. Hum Mutation, (1998). 12, 128–134.
Budowle, B, Chakraborty, R, Guisti, A, Eisenberg, A & Allen, C : Analysis of the VNTR locus D1S80 by the PCR followed by high-resolution PAGE. Am J Hum Genet, (1991). 48, 137–144.
Sander, T, Syagailo, Y, Samochowiec, J, Okladnova, O, Lesh, KP & Janz, D : Association analysis of a regulatory promoter polymorphism of the PAX6 gene with idiopathic generalized epilepsy. Epilepsy Res, (1999). 36, 61–67.
Hanson, IM, Seawright, A & Hardman, K : Pax6 mutations in aniridia. Hum Mol Genet, (1993). 7, 915–920.
Crolla, J, Cross, I, Atkey, N, Wright, M & Oley, C : FISH studies in a patients with sporadic aniridia and t(7;11)(q31.2;p13). J Med Genet, (1996). 33, 66–68.
Fantes, JA, Bickmore, WA, Fletcher, JM, Ballesta, F, Hanson, IM & van Heyningen, V : Submicroscopic deletions at the WAGR locus, revealed by nonradioactive in situ hybridization. Am J Hum Genet, (1992). 51, 1286–1294.
Calvas, P, Rozet, JM, Gerber, S, Munnich, A & Kaplan, J : Novel PAX6 paired-domain mutations in congenital aniridia and identification of a new alternative splicing of PAX6 mRNA. Am J Hum Genet, (1996). Suppl.59 A394, 2297
Jaworski, C, Sperbeck, S, Graham, C & Wistow, G : Alternative splicing of Pax6 in bovine eye and evolutionary conservation of intron sequences. BBR communications, (1997). 240, 196–202.
Grønskov, K, Rosenberg, T, Sand, A & Brondum Nielsen, K : Mutational analysis of PAX6: 16 novel mutations including 5 missense mutations with a mild aniridia phenotype. Eur J Hum Genet, (1999). 7, 274–286.
Axton, R, Hanson, I, Danes, S, Sellar, G, van Heyningen, V & Prosser, J : The incidence of PAX6 mutation in patients with simple aniridia: an evaluation of mutation detection in 12 cases. J Med Genet, (1997). 34, 279–286.
Lauderdale, J, Wilensky, J, Oliver, E, Walton, E, Walton, D & Glaser, T : 3′deletions cause aniridia by preventing PAX6 gene expression. PNAS, (2000). 97, 13755–13759.
Kondo-Saitoh, A, Matsumoto, N & Sasaki, T et al : Two nonsense mutations of Pax6 in two japanese aniridia families: cases report and review of the literature. Eur J Ophthalmol, (2000). 10, 167–172.
Gupta, S, De Becker, I, Guernsey, D & Neuman, P : Polymerase chain reaction-based risk assessment for Wilms tumor in sporadic aniridia. Am J Ophthalmol, (1998). 125, 687–692.
Churchill, A, Hanson, I & Markham, A : Prenatal diagnosis of aniridia. Ophthalmology, (2000). 107, 1153–1156.
Marquat, LE & Carmichael, GG : Quality control of mRNA function. Cell, (2001). 104, 173–176.
Byers, PH : Killing the messengers: new insights into nonsense-mediated mRNA decay. J Clin Invest, (2002). 109, 3–6.
Singh, S, Tang, HK, Lee, JY & Saunders, G : Truncation mutations in the transactivation region of the PAX6 result in dominant negative mutants. J Biol Chem, (1998). 273, 21531–21541.
Singh, S, Chao, L, Mishra, R, Davies, J & Saunders, G : Missense mutation at the C-terminus of PAX6 negatively modulates homeodomain function. Hum Mol Genet, (2001). 10, 911–918.
Deckwardt, S, Neu-Yilik, G, Thermann, R, Frede, U, Hentze, MW & Kulozik, AE : Abnormally spliced β-globin mRNAs: a single point mutation generates transcripts sensitive and insensitive to nonsense-mediated mRNA decay. Blood, (2002). 99, 1811–1816.
Hanson, IM, Churchill, A & Love, J et al : Missense mutations in the most ancient residues of the Pax6 paired domain underlie a spectrum of human congenital eye malformation. Hum Mol Genet, (1999). 8, 165–172.
Sonoda, S, Isashiki, Y, Tabata, Y, Kimura, K, Kakiuchi, T & Ohba, N : A novel Pax6 gene mutation (P118R) in a family with congenital nystagmus associated with a variant form of aniridia. Graefe's Arch Clin Exp Ophthalmol, (2000). 238, 552–558.
Syagailo, Y, Wilke, K & Okladnova, O et al : Different ocular abnormalities in individuals of a three generation family caused by a new nonsense mutation in the PST domain of the Pax6 gene. Hum. Mutation, (1998). on line mutation in brief 189
Acknowledgements
This work was supported by grants of the DRRC, from the CHU of Toulouse. We wish to thank all clinicians who sent us careful clinical examination and DNA samples especially Dr J Kaplan, Pr N Philipp, Dr P Malzac and Dr H Dollfus. We are grateful to Dr V van Heyningen of the MRC Human Genetics Unit, Edinburgh for having kindly provided the FAT5 and B2.1 cosmids. We would also like to thank Nicole Janisse, Anne-Marie Mazarguil and Sandra Ibos for technical assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vincent, MC., Pujo, AL., Olivier, D. et al. Screening for PAX6 gene mutations is consistent with haploinsufficiency as the main mechanism leading to various ocular defects. Eur J Hum Genet 11, 163–169 (2003). https://doi.org/10.1038/sj.ejhg.5200940
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.ejhg.5200940
Keywords
This article is cited by
-
Detection of a novel PAX6 variant in a Chinese family with multiple ocular abnormalities
BMC Ophthalmology (2022)
-
A novel variant in PAX6 as the cause of aniridia in a Chinese family
BMC Ophthalmology (2021)
-
Phenotype–genotype correlations and emerging pathways in ocular anterior segment dysgenesis
Human Genetics (2019)
-
Genetics of anophthalmia and microphthalmia. Part 1: Non-syndromic anophthalmia/microphthalmia
Human Genetics (2019)
-
Epistasis between Pax6Sey and genetic background reinforces the value of defined hybrid mouse models for therapeutic trials
Gene Therapy (2018)
